20052020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Daniela Gilardi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 17 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Multidisciplinary management of the nocebo effect in biosimilar-treated IBD patients: Results of a workshop from the NOCE-BIO consensus group

D'Amico, F., Pouillon, L., Argollo, M., Hart, A., Fiorino, G., Vegni, E., Radice, S., Gilardi, D., Fazio, M., Leone, S., Bonovas, S., Magro, F., Danese, S. & Peyrin-Biroulet, L., Feb 2020, In : Digestive and Liver Disease. 52, 2, p. 138-142 5 p.

Research output: Contribution to journalReview article

  • Anti-fibrotic Drugs for Crohn's Disease: Ready for Prime Time?

    Argollo, M., Gilardi, D., Roda, G., Fiorino, G., Peyrin-Biroulet, L. & Danese, S., 2019, In : Current Pharmaceutical Design. 25, 1, p. 47-56 10 p.

    Research output: Contribution to journalReview article

  • Biosimilars of adalimumab: the upcoming challenge in IBD

    Fiorino, G., Gilardi, D., Correale, C., Furfaro, F., Roda, G., Loy, L., Argollo, M., Allocca, M., Peyrin-Biroulet, L. & Danese, S., Oct 2019, In : Expert Opinion on Biological Therapy. 19, 10, p. 1023-1030 8 p.

    Research output: Contribution to journalArticle

  • Biosimilars of Adalimumab in Inflammatory Bowel Disease: Are we Ready for that?

    Argollo, M., Fiorino, G., Gilardi, D., Furfaro, F., Roda, G., Loy, L., Allocca, M., Peyrin-Biroulet, L. & Danese, S., 2019, In : Current Pharmaceutical Design. 25, 1, p. 7-12 6 p.

    Research output: Contribution to journalReview article